Home/Filings/5/0001178913-10-002410

5//SEC Filing

Dankner Nochi 5

Accession 0001178913-10-002410

CIK 0001451980other

View on SEC.gov Company Profile

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 10:02 AM ET

Size

25.8 KB

Accession

0001178913-10-002410

Insider Transaction Report

Form 5

Period: 2009-12-31

BIOCANCELL THERAPEUTICS INC.BICL

Clal Biotechnology Industries Ltd.

10% Owner

Transactions

Sale
Common Stock
2009-10-15$0.88/sh−4,228$3,738→ 3,838,445 total
Sale
Common Stock
2009-10-13$0.85/sh−5,500$4,666→ 3,842,673 total
Sale
Common Stock
2009-10-15$0.82/sh−4,000$3,278→ 3,834,445 total

CLAL INDUSTRIES & INVESTMENTS LTD

10% Owner

Transactions

Sale
Common Stock
2009-10-13$0.85/sh−5,500$4,666→ 3,842,673 total
Sale
Common Stock
2009-10-15$0.82/sh−4,000$3,278→ 3,834,445 total
Sale
Common Stock
2009-10-15$0.88/sh−4,228$3,738→ 3,838,445 total

IDB HOLDING CORP LTD

10% Owner

Transactions

Sale
Common Stock
2009-10-13$0.85/sh−5,500$4,666→ 3,842,673 total
Sale
Common Stock
2009-10-15$0.88/sh−4,228$3,738→ 3,838,445 total
Sale
Common Stock
2009-10-15$0.82/sh−4,000$3,278→ 3,834,445 total

Bergman Shelly

10% Owner

Transactions

Sale
Common Stock
2009-10-15$0.82/sh−4,000$3,278→ 3,834,445 total
Sale
Common Stock
2009-10-13$0.85/sh−5,500$4,666→ 3,842,673 total
Sale
Common Stock
2009-10-15$0.88/sh−4,228$3,738→ 3,838,445 total

Livnat Avraham

10% Owner

Transactions

Sale
Common Stock
2009-10-15$0.82/sh−4,000$3,278→ 3,834,445 total
Sale
Common Stock
2009-10-15$0.88/sh−4,228$3,738→ 3,838,445 total
Sale
Common Stock
2009-10-13$0.85/sh−5,500$4,666→ 3,842,673 total

IDB DEVELOPMENT CORP LTD

10% Owner

Transactions

Sale
Common Stock
2009-10-13$0.85/sh−5,500$4,666→ 3,842,673 total
Sale
Common Stock
2009-10-15$0.82/sh−4,000$3,278→ 3,834,445 total
Sale
Common Stock
2009-10-15$0.88/sh−4,228$3,738→ 3,838,445 total

Dankner Nochi

10% Owner

Transactions

Sale
Common Stock
2009-10-15$0.88/sh−4,228$3,738→ 3,838,445 total
Sale
Common Stock
2009-10-15$0.82/sh−4,000$3,278→ 3,834,445 total
Sale
Common Stock
2009-10-13$0.85/sh−5,500$4,666→ 3,842,673 total

Manor Ruth

10% Owner

Transactions

Sale
Common Stock
2009-10-15$0.82/sh−4,000$3,278→ 3,834,445 total
Sale
Common Stock
2009-10-13$0.85/sh−5,500$4,666→ 3,842,673 total
Sale
Common Stock
2009-10-15$0.88/sh−4,228$3,738→ 3,838,445 total

Footnotes (1)

[F1]The transaction was executed in New Israeli Shekel ("NIS"). The price indicated in the table is based on the exchange rate of NIS and US dollar last reported by the Bank of Israel (NIS 3.782 for US$1).

Documents

2 files

Issuer

BIOCANCELL THERAPEUTICS INC.

CIK 0001451980

→

Entity typeother

Related Parties

filerCIK 0001355204

Filing Metadata

Form type: 5
Filed: Sep 12, 8:00 PM ET
Accepted: Sep 13, 10:02 AM ET
Size: 25.8 KB

View on SEC.gov